ATAdam F. Teshev

Adam F. Teshev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adam F. Teshev has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biomechanical parameters of the fibrous capsule of the eyeball in pseudoexfoliative glaucoma in comparison with primary open-angle glaucoma

    by Alexey V. Malyshev, Anastasiya S. Apostolova, Aleksey A. Sergienko, Adam F. Teshev, Garry Yu. Karapetov, Marina K. Ashkhamakhova, Bella N. Khatsukova

    BACKGROUND: Pseudoexfoliation syndrome is currently considered as a systemic disorder of the connective tissue metabolism with the accumulation in all corneal cell layers of pseudoexfoliation syndrome deposits, which disrupt corneal morphology and biomechanics. AIM: to study the features of biomechanical parameters of the fibrous capsule of eyes in primary open-angle glaucoma (POAG) in comparison with those in pseudoexfoliative glaucoma (PEG). MATERIALS AND METHODS: We compared 65 eyes with POAG and 77 eyes with PEG aged under 80 years. The control group consisted of 18 healthy eyes. Biomechanical indicators were compared, such as: DA Ratio, Integr. Radius, SP-A1, SSI, BGF, biomechanically corrected intraocular pressure (bIOP) obtained with Pentacam (Oculus) and CorVis ST. RESULTS: Patients with PEG were elder (68.013 ± 0.75 years) in contrast to POAG patients (60.03 ± 1.05 years) (p = 0.001), had a thinner central retinal thickness (CRT) — 543.99 ± 3.9 µm versus 559.33 ± 4.4 µm in those with POAG (p = 0.010). The IOP level did not differ between groups, and no correlation with CRT was detected. Indicators of corneal stiffness: DA ratio Integr. Radius did not differ between POAG, PEG and control group. The SP-A1 parameter also did not differ between POAG and PEG patients, while there were differences between PEG patients and the control group (p = 0.046). Moreover, in eyes with POAG, SP-A1 directly correlates with IOP Ро (p = 0.001) and CRT (p = 0.001), in those with PEG — p = 0.001 and p = 0.001, respectively. The SSI index in PEG was higher and amounted to 1.38 ± 0.03 versus 1.27 ± 0.03 in POAG (p = 0.013), while it correlated with age only in the case of PEG (p = 0.007). A correlation between SSI and CTR was also revealed — in POAG (p = 0.018), in PEG (p = 0.001). In PEG, BGF shows higher values (25.92 ± 2.3) than in POAG (17.71 ± 2.2; p = 0.010). BGF has no correlation with age (p = 0.094 and p = 0.737 for POAG and PEG, respectively), depends on CRT (p = 0.001 and p = 0.027, respectively), on bIOP (p = 0.001 and p = 0.001, respectively), and on SP-A1 (p = 0.009 and p = 0.001, respectively). The only parameter that was higher in PEG than in POAG was SSI, which did not correlate with the BGF indicator (p = 0.642 and p = 0.327, respectively). CONCLUSIONS: We did not find any fundamental differences in biomechanics between PEG and POAG, which could explain the significant rates of progression of PEG. Based on our data, it is obvious that the eye with PEG differs from that with POAG being more rigid, even at similar IOP values.

  • Open Access

    Experience of micropulse transscleral cyclophotocoagulation in glaucoma with decompensated intraocular pressure

    by A. V. Malyshev, A. S. Apostolova, A. A. Sergienko, A. F. Teshev, G. Yu. Karapetov, M. K. Ashkhamakhova, B. N. Khatsukova

    PURPOSE. To evaluate the effectiveness of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with decompensated glaucoma.METHODS. The analysis included a total of 54 eyes with decompensated glaucoma that underwent MP-TSCPC. The mean age was 62.83±1.75 years. The follow-up period lasted up to 3 months. Advanced-stage glaucoma was observed in 18 eyes, and terminal-stage glaucoma in 34 eyes. Primary glaucoma was present in 37 eyes, and secondary glaucoma in 14 eyes. A reduction in intraocular pressure (IOP) of more than 20% from baseline was considered a successful outcome.RESULTS. The baseline IOP was 38.97±1.94 mm Hg, with an overall hypotensive effect of 26%. The overall effectiveness of mCPC was 75.9%.In terminal-stage glaucoma, IOP reduction by the end of the third month after MP-TSCPC was 23%, with an effectiveness of 76.5%. In advanced-stage glaucoma, IOP decreased by 16% by the end of the third month, with an effectiveness of 75%.For primary glaucoma, the IOP reduction at 3 months was 32.5%, and for secondary glaucoma, it was 22%. Prior to MP-TSCPC, patients had been using an average of 3.075 types of eye drops, which remained unchanged after the procedure. The effectiveness of MP-TSCPC did not differ between operated and non-operated eyes. When MP-TSCPC was performed to relieve pain, success was achieved in all cases. During the study period, one patient underwent a repeat MP-TSCPC, and another underwent an antiglaucoma filtering surgery. No complications were observed in any of the cases.CONCLUSION. MP-TSCPC is an effective intervention with a safe early postoperative period. We observed a significant hypotensive effect in eyes with preserved visual function and effective pain relief. Further follow-up of these patients is necessary, as well as the expansion of indications for use in earlier stages.

  • Bilateral, sequential implantation of an intraocular lens of special design with four-point sclero-corneal flange fixation in aphakia

    by Maykop Adygea Republican Clinical Hospital, A.F. Teshev, A.V. Malyshev, K.P. Telegin, St. Petersburg City Hospital No. 40 Of The Kurortnii District Sestroretsk, R.K. Adzhiev

    Bilateral, sequential implantation of an intraocular lens of special design with four-point sclero-corneal flange fixation in aphakia A.F. Teshev, A.V. Malyshev, K.P. Telegin, R.Kh. Adzhiev Adygea Republican Clinical Hospital, Maykop, Republic of Adygea, Russian Federation Maykop State Technological University, Republic of Adygea, Russian Federation Research Institute – Regional Clinical Hospital No. 1 named after Professor S. V. Ochapovskii Krasnodar, Russian Federation City Hospital No. 40 of the Kurortnii district Sestroretsk, St. Petersburg, The article describes a clinical case with surgical treatment of bilateral aphakia in a patient who underwent cataract removal 50 years ago through a wide limbal incision. This case is interesting due to the approach to surgical treatment, namely the choice of intraocular lens, the method of fixing the intraocular lens in the absence of a capsular bag, and the results of visual acuity obtained. Key words: aphakia, sclerocorneal fixation of IOLs, intraocular lens, IOL stitching, Aquamarine nanocrystal model ACQ11.03IOL (Aquamarine TT)

  • Open Access

    Comparative evaluation of the hypotensive effect of brimonidine and its fixed combination with timolol

    by A. V. Malyshev, A. S. Apostolova, A. A. Sergienko, A. F. Teshev, G. Yu. Karapetov, M. K. Ashkhamakhova, U. I. Midaev

    PURPOSE. To evaluate the hypotensive efficacy of a single instillation of brimonidine 0.15% Purit or a fixed combination of brimonidine 0.2% and timolol 0.5% (FCBT) in various forms of glaucoma and ocular hypertension (OH).METHODS. Brimonidine 0.15% or FCBT was instilled in 285 eyes with uncompensated glaucoma and OH. Brimonidine 0.15% was instilled in patients with OH, early and moderate glaucoma, initially moderately elevated IOP (b), newly diagnosed pathology without previous therapy. FCBT was instilled in patients with initially high IOP (c), advanced and terminal stages, who were on therapy. The hypotensive effect was evaluated after 20 minutes. The mean age of the patients was 64.94±0.952 years. Women were predominant in the study group — 62.5%, men comprised 37.5%.RESULTS. The maximum efficacy was observed in the age group of 60–79 years and over 80 — 27.30±1.1% and 32.46±0.9%. The greatest hypotensive effect was observed in angle-closure glaucoma — 31.69±3.5%. In newly diagnosed glaucoma, intraocular pressure (IOP) decreased by 24.95±1.14%; when added to previous mono- and combination therapy, the decrease was 27.48±2.0% and 25.88±2.7% (p=0.64). In the early and moderate stages, the decrease was 23.68±1.6%, 26.8±2.3%, respectively. The maximum effect (30.64±2.25%) was observed in the advanced stage. At more than 30 mm Hg, the decrease was more than 30%. The hypotensive effect of FCBT was twice that of brimonidine — 22.5±0.97% and 33.27±1.43%, respectively (pCONCLUSION. We recommend using brimonidine 0.15% or FCBT for elevated IOP in all types of glaucoma and OH: brimonidine 0.15% when the initial IOP is less than 30 mm Hg, and FCBT — when it is more than 30 mm Hg. The use of both drugs is most effective in people over 60 years of age. Brimonidine 0.15% can be recommended as a starting therapy for early glaucoma and OH with an initial IOP of less than 30 mm Hg. In case of IOP more than 30 mm Hg, advanced or angleclosure glaucoma, or glaucoma uncompensated while on therapy, it is preferable to prescribe FCBT due to its greater hypotensive effect.

  • Qualitative expert assessment of the condition of a patient's ocular fundus in severe and advanced stages of proliferative diabetic retinopathy

    by Adam F. Teshev, Alexey V. Malyshev

    Objective: comparative qualitative expert assessment of the condition of the patient's fundus in severe and advanced stages of proliferative diabetic retinopathy (PDR). Material and methods. An assessment was made of the developed qualitative criteria for the condition of the fundus in patients with the following stages of PDR: severe-high risk 1 (SHRPDR-1, 32 eyes), severe-high risk 2 (SHRPDR-2, 32 eyes) and advanced (APDR, 34 eyes). The developed criteria (preretinal hemorrhage, fibrosis of the posterior hyaloid membrane, vitreous hemorrhage, etc.) were assessed by one ophthalmic surgeon on a point scale: 1 point — initial changes; 2 — weak, but more pronounced (compared to 1 point) changes; 3 — severity of moderate changes; 4 — pronounced changes. Results. The greatest increase in the average score in the group of patients with APDR (compared with SHRPDR-1 and SHRPDR-2) was established according to the following criteria: fibrovascular tissue in the area of the optic nerve head and along the vascular arcades (2 times), fibrosis of the posterior hyaloid membrane (1.5 times), vitreous hemorrhage (1.4 times); for other criteria, the increase in average score varies from 28 to 93%. At the same time, there is only a tendency for the criteria to worsen between SHRPDR-1 and SHRPDR-2 (p>0.05). Conclusion. A significant deterioration of all criteria was established in patients with APDR compared with SHRPDR-1 and SHRPDR-2.

  • Open Access

    Quality of life of patients with an advanced stage of proliferative diabetic retinopathy after application of various vitrectomy technologies

    by A. F. Teshev, A. V. Malyshev

    Purpose: A comparative assessment of quality of life (QL) after the use of various vitrectomy (VE) technologies in patients with an advanced stage of proliferative diabetic retinopathy (ASPDR).Material and methods. We examined 132 patients aged 42 to 76 (average age 62.8 ± 2.4 years) who met the classification criteria of ASPDR: impossibility to estimate the area of neovascularization; the fundus of the eye in the posterior pole cannot be seen or can only partialy be seen using an ophthalmoscope; evidence of preretinal or vitreal hemorrhage in the posterior pole with an area of more than 4 optic discs and retinoschisis in the macular zone. All patients were divided into two groups, comparable in age, gender and visual status of the “healthy” eye: the main group (69 eyes), in which VE was performed according to the technique developed by the authors, and the control (63 eyes), in which the traditional VE technique was used. QL was assessed before surgery and 3 months after it using the VFQ-25 and QL-20 questionnaires.Results. QL was found to be higher when the new surgery technique was used: the data of VFA-25 showed a 12.9% increase (p < 0.05) and QL-20 showed a 29.2% increase (p < 0.01), which points to a higher clinical effectiveness of the newly developed surgical treatment technique than that of the traditional technique.Conclusion. The results obtained are related to the ophthalmological features of the developed surgical treatment of ASPDR: combined (phacoemulsification of cataracts + IOL + vitrectomy) one-stage intervention, lack of drainage of subretinal fluid, etc.), medication support (preliminary intravitreal administration of an angiogenesis inhibitor) and anesthesia (intervention under local anesthesia with intravenous sedation). The differences are most effectively identified using the special QL-20 questionnaire.


  • Proliferative diabetic retinopathy in severe stages: modern approaches to diagnosis and treatment (systematic review)

    by Adam F. Teshev, Alexey V. Malyshev, Aleksandr S. Golovin

    Diabetic retinopathy (DR) is a leading complication in patients with diabetes mellitus (DM). Because of the increase in the clinical effectiveness of treatment for diabetes, the life expectancy of patients has increased, which accordingly increases the risk of severe forms of DR (proliferative DR), which is one of the main causes of blindness and low vision in the working-age population. In the literature, the overall prevalence of DR and proliferative DR is up to 34.6% and 12.0%, respectively, whereas 25% of cases of vision loss associated with DR are caused by complications of proliferative DR. Colour fundus photography and optical coherence tomography are the most informative clinical diagnostic methods for DR. In severe stages of proliferative DR, the information content of the presented indicators can be significantly reduced because of insufficient visualisation of the patient’s fundus. Thus, the literature proposes qualitative criteria (specific and single indicators) based on an expert assessment of the condition of the fundus by an ophthalmic surgeon. The described approach has a fairly high diagnostic efficiency. Along with this, it appears relevant to study the ‘quality of life’ of a patient with symptoms of proliferative DR caused by the occurrence of characteristic manifestations of psychological distress (psychological and anxiety disorders and depression). In surgical terms, functional results notably improved after vitrectomy for proliferative DR in 49–83% of cases. Moreover, the proposed methods for conducting vitrectomy for patients with advanced stages of proliferative DR do not fully consider ophthalmological and somatic features, which requires the consideration of the surgical treatment of this contingent as a separate area of vitrectomy for improving ophthalmological ‘techniques’, drug support and choice of anaesthesia.


  • Influence of certain factors on adherence to treatment in glaucoma patients in clinical practice

    by Alexey V. Malyshev, Anastasiya S. Apostolova, Aleksey A. Sergienko, Adam F. Teshev, Garry Y. Karapetov, Marina K. Ashhamahova, Umar I. Midaev

    BACKGROUND: Up to 80% of patients do not comply with the treatment regimen, and this leads to the progression of the disease. AIM: The aim of this study is the analysis of adherence to treatment based on a questionnaire survey of glaucoma patients. MATERIALS AND METHODS: 139 patients with glaucoma were questioned. The mean age was 67.19 0.84 years, 63.3% were women, 36.7% were men. 73.4% were city residents, 26.6% village residents. 26% were diagnosed less than a year before, 34.5% 15 years before, 39.5% 5 years or more before. 47.5% received only medical therapy, the rest had a history of surgery as well. Statistical processing of the obtained results was carried out using the standard statistical analysis software package SPSS Statistics 16.0. The parameters with a normal distribution were presented as M m, where M is the mean value, m is the standard error of the mean. RESULTS: On average, patients received 2.1 0.08 molecules in 1.64 0.06 vials. 48% of patients did not observe the frequency of visits to the ophthalmologist. Violation of adherence was present in 40.5% of cases, the main reason was forgetfulness (51%), 24.5% did not buy the medication on time, discomfort on instillation was reported in 7% of cases, systemic side effects in 3.5%, other reasons in 14%. Adherence does not depend on the duration of glaucoma, the number of vials, the place of residence. Contraindications to the prescription of -blockers were present in 30% of cases. CONCLUSIONS: The study has confirmed that nearly half of patients are non-adherent to treatment due to forgetfulness.